Drug
Delamanid Obr
Delamanid Obr: highest development phase Phase 3, developed by Otsuka. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Otsuka
Trials
| Drug | Phase | Indication |
|---|---|---|
| Delamanid + OBR NCT01424670 | Phase 3 | Multidrug-resistant Tuberculosis |
Latest
No recent events.
Follow Delamanid Obr on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.